233 related articles for article (PubMed ID: 26602016)
21. Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma.
Kawakami H; Okamoto I; Terao K; Sakai K; Suzuki M; Ueda S; Tanaka K; Kuwata K; Morita Y; Ono K; Nishio K; Nishimura Y; Doi K; Nakagawa K
Cancer Med; 2013 Dec; 2(6):933-41. PubMed ID: 24403267
[TBL] [Abstract][Full Text] [Related]
22. Influence of HPV-status on survival of patients with tonsillar carcinomas (TSCC) treated by CO
Hoffmann M; Quabius ES; Tribius S; Gebhardt S; Görögh T; Hedderich J; Huber K; Dunst J; Ambrosch P
Cancer Lett; 2018 Jan; 413():59-68. PubMed ID: 29100961
[TBL] [Abstract][Full Text] [Related]
23. Comparing Outcomes for Patients with Human Papillomavirus (HPV) Type 16 versus Other High-Risk HPV Types in Oropharyngeal Squamous Cell Carcinoma.
Shenker RF; May NH; Waltonen JD; Yang JP; O'Neill SS; Frizzell BA; Greven KM; Hughes RT
Head Neck Pathol; 2021 Sep; 15(3):866-874. PubMed ID: 33616854
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors for human papillomavirus-positive and negative oropharyngeal carcinomas.
Yin LX; D'Souza G; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig EM; Ryan WR; Ha PK; Wentz A; Koch W; Eisele DW; Fakhry C
Laryngoscope; 2018 Aug; 128(8):E287-E295. PubMed ID: 29536542
[TBL] [Abstract][Full Text] [Related]
25. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
[TBL] [Abstract][Full Text] [Related]
26. Primary surgery results in no survival benefit compared to primary radiation for oropharyngeal cancer patients stratified by high-risk human papilloma virus status.
Lybak S; Ljøkjel B; Haave H; Karlsdottir À; Vintermyr OK; Aarstad HJ
Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):477-487. PubMed ID: 27491318
[TBL] [Abstract][Full Text] [Related]
27. Human papillomavirus-associated head and neck squamous cell carcinoma survival: a comparison by tumor site and initial treatment.
Salazar CR; Smith RV; Garg MK; Haigentz M; Schiff BA; Kawachi N; Anayannis N; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
Head Neck Pathol; 2014 Mar; 8(1):77-87. PubMed ID: 24002971
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of non-HPV16 genotypes in oropharyngeal squamous cell carcinoma.
Mazul AL; Rodriguez-Ormaza N; Taylor JM; Desai DD; Brennan P; Anantharaman D; Gheit T; Tommasino M; Abedi-Ardekani B; Olshan AF; Zevallos JP
Oral Oncol; 2016 Oct; 61():98-103. PubMed ID: 27688111
[TBL] [Abstract][Full Text] [Related]
29. Impact of specific high-risk human papillomavirus genotypes on survival in oropharyngeal cancer.
Garset-Zamani M; Carlander AF; Jakobsen KK; Friborg J; Kiss K; Marvig RL; Olsen C; Nielsen FC; Andersen E; Grønhøj C; von Buchwald C
Int J Cancer; 2022 Apr; 150(7):1174-1183. PubMed ID: 34894151
[TBL] [Abstract][Full Text] [Related]
30. Human Papillomavirus 16 Infection and TP53 Mutation: Two Distinct Pathogeneses for Oropharyngeal Squamous Cell Carcinoma in an Eastern Chinese Population.
Wang Z; Xia RH; Ye DX; Li J
PLoS One; 2016; 11(10):e0164491. PubMed ID: 27749915
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus integration pattern and demographic, clinical, and survival characteristics of patients with oropharyngeal squamous cell carcinoma.
Lim MY; Dahlstrom KR; Sturgis EM; Li G
Head Neck; 2016 Aug; 38(8):1139-44. PubMed ID: 27002307
[TBL] [Abstract][Full Text] [Related]
32. Incidence and Demographic Burden of HPV-Associated Oropharyngeal Head and Neck Cancers in the United States.
Mahal BA; Catalano PJ; Haddad RI; Hanna GJ; Kass JI; Schoenfeld JD; Tishler RB; Margalit DN
Cancer Epidemiol Biomarkers Prev; 2019 Oct; 28(10):1660-1667. PubMed ID: 31358520
[TBL] [Abstract][Full Text] [Related]
33. Oral health and human papillomavirus-associated head and neck squamous cell carcinoma.
Mazul AL; Taylor JM; Divaris K; Weissler MC; Brennan P; Anantharaman D; Abedi-Ardekani B; Olshan AF; Zevallos JP
Cancer; 2017 Jan; 123(1):71-80. PubMed ID: 27571516
[TBL] [Abstract][Full Text] [Related]
34. Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.
Ko HC; Harari PM; Sacotte RM; Chen S; Wieland AM; Yu M; Baschnagel AM; Bruce JY; Kimple RJ; Witek ME
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2341-2350. PubMed ID: 28752235
[TBL] [Abstract][Full Text] [Related]
35. A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma.
Deng Z; Hasegawa M; Aoki K; Matayoshi S; Kiyuna A; Yamashita Y; Uehara T; Agena S; Maeda H; Xie M; Suzuki M
Int J Oncol; 2014 Jul; 45(1):67-76. PubMed ID: 24820457
[TBL] [Abstract][Full Text] [Related]
36. Improved survival of Japanese patients with human papillomavirus-positive oropharyngeal squamous cell carcinoma.
Mizumachi T; Kano S; Sakashita T; Hatakeyama H; Suzuki S; Homma A; Oridate N; Fukuda S
Int J Clin Oncol; 2013 Oct; 18(5):824-8. PubMed ID: 22936564
[TBL] [Abstract][Full Text] [Related]
37. Nonuniform Distribution of High-risk Human Papillomavirus in Squamous Cell Carcinomas of the Oropharynx: Rethinking the Anatomic Boundaries of Oral and Oropharyngeal Carcinoma From an Oncologic HPV Perspective.
Gelwan E; Malm IJ; Khararjian A; Fakhry C; Bishop JA; Westra WH
Am J Surg Pathol; 2017 Dec; 41(12):1722-1728. PubMed ID: 28877058
[TBL] [Abstract][Full Text] [Related]
38. Disparities in survival outcomes among Black patients with HPV-associated oropharyngeal cancer.
Baliga S; Mitchell D; Yildiz VO; Gogineni E; Konieczkowski DJ; Grecula J; Blakaj DM; Liu X; Gamez ME
J Med Virol; 2023 Feb; 95(2):e28448. PubMed ID: 36583477
[TBL] [Abstract][Full Text] [Related]
39. Human Papillomavirus Drives Tumor Development Throughout the Head and Neck: Improved Prognosis Is Associated With an Immune Response Largely Restricted to the Oropharynx.
Chakravarthy A; Henderson S; Thirdborough SM; Ottensmeier CH; Su X; Lechner M; Feber A; Thomas GJ; Fenton TR
J Clin Oncol; 2016 Dec; 34(34):4132-4141. PubMed ID: 27863190
[TBL] [Abstract][Full Text] [Related]
40. HPV Status Improves Classification of Head and Neck Gray Zone Cancers.
Ren J; Xu W; Su J; Ren X; Bender N; Habbous S; de Almeida JR; Goldstein DP; Cheng D; Chen Z; Mirshams M; Rahini M; Huang SH; Spreafico A; Hansen A; Kim J; Waldron J; Perez-Ordonez B; Zhao Y; Hung R; Waterboer T; Liu G
J Dent Res; 2019 Jul; 98(8):879-887. PubMed ID: 31282843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]